Alleviating Pancreatic Cancer-Associated Pain Using Endoscopic Ultrasound-Guided Neurolysis

The most common symptom in patients with advanced pancreatic cancer is abdominal pain. This has traditionally been treated with nonsteroidal anti-inflammatory drugs and opioid analgesics. However, these treatments result in inadequate pain control or drug-related adverse effects in some patients. An...

Full description

Bibliographic Details
Main Authors: Kosuke Minaga, Mamoru Takenaka, Ken Kamata, Tomoe Yoshikawa, Atsushi Nakai, Shunsuke Omoto, Takeshi Miyata, Kentaro Yamao, Hajime Imai, Hiroki Sakamoto, Masayuki Kitano, Masatoshi Kudo
Format: Article
Language:English
Published: MDPI AG 2018-02-01
Series:Cancers
Subjects:
Online Access:http://www.mdpi.com/2072-6694/10/2/50
_version_ 1797715714949251072
author Kosuke Minaga
Mamoru Takenaka
Ken Kamata
Tomoe Yoshikawa
Atsushi Nakai
Shunsuke Omoto
Takeshi Miyata
Kentaro Yamao
Hajime Imai
Hiroki Sakamoto
Masayuki Kitano
Masatoshi Kudo
author_facet Kosuke Minaga
Mamoru Takenaka
Ken Kamata
Tomoe Yoshikawa
Atsushi Nakai
Shunsuke Omoto
Takeshi Miyata
Kentaro Yamao
Hajime Imai
Hiroki Sakamoto
Masayuki Kitano
Masatoshi Kudo
author_sort Kosuke Minaga
collection DOAJ
description The most common symptom in patients with advanced pancreatic cancer is abdominal pain. This has traditionally been treated with nonsteroidal anti-inflammatory drugs and opioid analgesics. However, these treatments result in inadequate pain control or drug-related adverse effects in some patients. An alternative pain-relief modality is celiac plexus neurolysis, in which the celiac plexus is chemically ablated. This procedure was performed percutaneously or intraoperatively until 1996, when endoscopic ultrasound (EUS)-guided celiac plexus neurolysis was first described. In this transgastric anterior approach, a neurolytic agent is injected around the celiac trunk under EUS guidance. The procedure gained popularity as a minimally invasive approach and is currently widely used to treat pancreatic cancer-associated pain. We focus on two relatively new techniques of EUS-guided neurolysis: EUS-guided celiac ganglia neurolysis and EUS-guided broad plexus neurolysis, which have been developed to improve efficacy. Although the techniques are safe and effective in general, some serious adverse events including ischemic and infectious complications have been reported as the procedure has gained widespread popularity. We summarize reported clinical outcomes of EUS-guided neurolysis in pancreatic cancer (from the PubMed and Embase databases) with a goal of providing information useful in developing strategies for pancreatic cancer-associated pain alleviation.
first_indexed 2024-03-12T08:10:47Z
format Article
id doaj.art-71e59400d81e41d3aeea58ca7bc5fa35
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-12T08:10:47Z
publishDate 2018-02-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-71e59400d81e41d3aeea58ca7bc5fa352023-09-02T19:08:20ZengMDPI AGCancers2072-66942018-02-011025010.3390/cancers10020050cancers10020050Alleviating Pancreatic Cancer-Associated Pain Using Endoscopic Ultrasound-Guided NeurolysisKosuke Minaga0Mamoru Takenaka1Ken Kamata2Tomoe Yoshikawa3Atsushi Nakai4Shunsuke Omoto5Takeshi Miyata6Kentaro Yamao7Hajime Imai8Hiroki Sakamoto9Masayuki Kitano10Masatoshi Kudo11Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama 589-8511, JapanDepartment of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama 589-8511, JapanDepartment of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama 589-8511, JapanDepartment of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama 589-8511, JapanDepartment of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama 589-8511, JapanDepartment of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama 589-8511, JapanDepartment of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama 589-8511, JapanDepartment of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama 589-8511, JapanDepartment of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama 589-8511, JapanDepartment of Gastroenterology, Katsuragi Hospital, Kishiwada 596-0825, JapanSecond Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, JapanDepartment of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka-Sayama 589-8511, JapanThe most common symptom in patients with advanced pancreatic cancer is abdominal pain. This has traditionally been treated with nonsteroidal anti-inflammatory drugs and opioid analgesics. However, these treatments result in inadequate pain control or drug-related adverse effects in some patients. An alternative pain-relief modality is celiac plexus neurolysis, in which the celiac plexus is chemically ablated. This procedure was performed percutaneously or intraoperatively until 1996, when endoscopic ultrasound (EUS)-guided celiac plexus neurolysis was first described. In this transgastric anterior approach, a neurolytic agent is injected around the celiac trunk under EUS guidance. The procedure gained popularity as a minimally invasive approach and is currently widely used to treat pancreatic cancer-associated pain. We focus on two relatively new techniques of EUS-guided neurolysis: EUS-guided celiac ganglia neurolysis and EUS-guided broad plexus neurolysis, which have been developed to improve efficacy. Although the techniques are safe and effective in general, some serious adverse events including ischemic and infectious complications have been reported as the procedure has gained widespread popularity. We summarize reported clinical outcomes of EUS-guided neurolysis in pancreatic cancer (from the PubMed and Embase databases) with a goal of providing information useful in developing strategies for pancreatic cancer-associated pain alleviation.http://www.mdpi.com/2072-6694/10/2/50endoscopic ultrasoundEUSEUS-guided neurolysisneurolysisinterventional EUSpancreatic cancerpain
spellingShingle Kosuke Minaga
Mamoru Takenaka
Ken Kamata
Tomoe Yoshikawa
Atsushi Nakai
Shunsuke Omoto
Takeshi Miyata
Kentaro Yamao
Hajime Imai
Hiroki Sakamoto
Masayuki Kitano
Masatoshi Kudo
Alleviating Pancreatic Cancer-Associated Pain Using Endoscopic Ultrasound-Guided Neurolysis
Cancers
endoscopic ultrasound
EUS
EUS-guided neurolysis
neurolysis
interventional EUS
pancreatic cancer
pain
title Alleviating Pancreatic Cancer-Associated Pain Using Endoscopic Ultrasound-Guided Neurolysis
title_full Alleviating Pancreatic Cancer-Associated Pain Using Endoscopic Ultrasound-Guided Neurolysis
title_fullStr Alleviating Pancreatic Cancer-Associated Pain Using Endoscopic Ultrasound-Guided Neurolysis
title_full_unstemmed Alleviating Pancreatic Cancer-Associated Pain Using Endoscopic Ultrasound-Guided Neurolysis
title_short Alleviating Pancreatic Cancer-Associated Pain Using Endoscopic Ultrasound-Guided Neurolysis
title_sort alleviating pancreatic cancer associated pain using endoscopic ultrasound guided neurolysis
topic endoscopic ultrasound
EUS
EUS-guided neurolysis
neurolysis
interventional EUS
pancreatic cancer
pain
url http://www.mdpi.com/2072-6694/10/2/50
work_keys_str_mv AT kosukeminaga alleviatingpancreaticcancerassociatedpainusingendoscopicultrasoundguidedneurolysis
AT mamorutakenaka alleviatingpancreaticcancerassociatedpainusingendoscopicultrasoundguidedneurolysis
AT kenkamata alleviatingpancreaticcancerassociatedpainusingendoscopicultrasoundguidedneurolysis
AT tomoeyoshikawa alleviatingpancreaticcancerassociatedpainusingendoscopicultrasoundguidedneurolysis
AT atsushinakai alleviatingpancreaticcancerassociatedpainusingendoscopicultrasoundguidedneurolysis
AT shunsukeomoto alleviatingpancreaticcancerassociatedpainusingendoscopicultrasoundguidedneurolysis
AT takeshimiyata alleviatingpancreaticcancerassociatedpainusingendoscopicultrasoundguidedneurolysis
AT kentaroyamao alleviatingpancreaticcancerassociatedpainusingendoscopicultrasoundguidedneurolysis
AT hajimeimai alleviatingpancreaticcancerassociatedpainusingendoscopicultrasoundguidedneurolysis
AT hirokisakamoto alleviatingpancreaticcancerassociatedpainusingendoscopicultrasoundguidedneurolysis
AT masayukikitano alleviatingpancreaticcancerassociatedpainusingendoscopicultrasoundguidedneurolysis
AT masatoshikudo alleviatingpancreaticcancerassociatedpainusingendoscopicultrasoundguidedneurolysis